Kissei Pharmaceutical Co., Ltd. (TYO:4547)
Japan · Delayed Price · Currency is JPY 4,185.00
+60.00 (1.45%)
Jul 16, 2025, 3:30 PM JST
Kissei Pharmaceutical Revenue
In the fiscal year ending March 31, 2025, Kissei Pharmaceutical had annual revenue of 88.33B JPY with 16.87% growth. Kissei Pharmaceutical had revenue of 22.66B in the quarter ending March 31, 2025, with 27.88% growth.
Revenue
88.33B
Revenue Growth
+16.87%
P/S Ratio
1.94
Revenue / Employee
49.68M
Employees
1,778
Market Cap
170.92B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| HOYA Corporation | 866.03B |
| Daiichi Sankyo Company | 1,886.26B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Shionogi & | 438.27B |
Kissei Pharmaceutical News
- 2 months ago - Rigel Reports First Quarter 2025 Financial Results and Provides Business Update - Benzinga